The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1003
June 20, 1997
View Complete Issue         Table of Contents 2019 
Midodrine for Orthostatic Hypotension
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Midodrine for Orthostatic Hypotension
June 20, 1997 (Issue: 1003)
Midodrine hydrochloride (ProAmatine - Roberts), an alpha1-selective adrenergic agonist, is now available for treatment of severe symptomatic orthostatic hypotension. Other treatments for this condition include other sympathomimetics, constrictive...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Midodrine for Orthostatic Hypotension
Article code: 1003c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.